Prophylaxis and Outcome Measures of Venous Thromboembolism in Admitted Patients at a Tertiary Care Hospital

Authors

  • Sugreev Dwivedi Anuj Department of Pharmacy Practice, Parul Institute of Pharmacy and Research, Parul University, Vadodara-391760, Gujarat, India
  • Saurabh Bhan Singh Department of Pharmacy Practice, Parul Institute of Pharmacy, Parul University, Vadodara-391760, Gujarat, India
  • Tarun Tank Department of Pharmacy Practice, Parul Institute of Pharmacy, Parul University, Vadodara-391760, Gujarat, India
  • Yash Gundecha Department of Pharmacy Practice, Parul Institute of Pharmacy, Parul University, Vadodara-391760, Gujarat, India
  • Harsh Sonar Department of Pharmacy Practice, Parul Institute of Pharmacy, Parul University, Vadodara-391760, Gujarat, India
  • Tejas B Patel Department of General Surgery, Parul Sevashram Hospital, Vadodara-391760, Gujarat, India

DOI:

https://doi.org/10.26452/ijcpms.v2i2.278

Keywords:

Venous Thromboembolism, Hospitalized Patients, Risk Stratification, Thrombo-Prophylaxis

Abstract

Deep vein thrombosis and pulmonary embolism are significant reasons of chronic illness & death in people suffering from venous thromboembolism (VTE). The goal of this study was to evaluate venous VTE risks, prevention, and outcomes in medical wards of a tertiary care hospital in Vadodara, Gujarat. The tool from the ACCP guideline on VTE prevention and therapy was used in a retrospective cross-sectional analysis including 200 patients' charts reviewed in those hospitalized to medical wards. MS Excel was used to input the data, which was subsequently uploaded to the SPSS 21 dataset for analysis. 186 (93 percent) of 200 medically hospitalized patients had at least two risk indicators for VTE development. Only 75 (40%) of the patients got thrombo-prophylaxis, and only 61 (32.8%) of those who obtained prophylaxis had VTE. However, 22 (11%) of the study participants in the high and highest risk categories experienced VTE within their hospital admission. Because such information was not included on patients' records, the status of VTE result was unknown to 128/200 (64 percent) research participants. All of the patients in this research have at least one VTE risk factor. Thromboprophylaxis was given to just 37.5 percent of patients. Current evidence-based guidelines provided by ACCP must be implemented.

Downloads

Download data is not yet available.

Published

2022-04-18

How to Cite

Sugreev Dwivedi Anuj, Saurabh Bhan Singh, Tarun Tank, Yash Gundecha, Harsh Sonar, & Tejas B Patel. (2022). Prophylaxis and Outcome Measures of Venous Thromboembolism in Admitted Patients at a Tertiary Care Hospital. International Journal of Clinical Pharmacokinetics and Medical Sciences, 2(2), 54–60. https://doi.org/10.26452/ijcpms.v2i2.278

Issue

Section

Original Article